MapLight Therapeutics, Inc. - Common Stock (MPLT) — AI analysis & news
MapLight Therapeutics, Inc. - Common Stock (MPLT) stock: 5 recent news items, slightly negative aggregate sentiment, AI analysis and market context on…
Current sentiment read
Across the last 5 indexed MPLT stories, aggregate finance-aware sentiment is slightly negative (-0.14 on a -1 to +1 scale).
Latest MPLT news
- MapLight Therapeutics’ Kreitzer sells $96,024 in common stock By Investing.com - Investing.com UK · Investing.com UK
- MapLight Therapeutics CMO Erin Foff sells $124,068 in stock By Investing.com - Investing.com India · Investing.com India
- MapLight Therapeutics CAO sells $82,149 in shares By Investing.com - Investing.com UK · Investing.com UK
- Form 4 MapLight Therapeutics Inc For: 26 September By Investing.com - Investing.com Australia · Investing.com Australia
- Form 4 MapLight Therapeutics Inc For: 26 September By Investing.com - Investing.com Nigeria · Investing.com Nigeria
FAQ
What is the current sentiment for MPLT stock?
Aggregate finance-aware sentiment across the last 5 indexed MPLT news stories is slightly negative (-0.14 on a -1 to +1 scale).